Praveen Rajendran

I am a cancer researcher...

[Praveen Rajendran @praveendran]

Gut health explained: What’s worth following and what’s just hype? My opinions are also in this article... https://t.co/Tz0nly7QUE

[Praveen Rajendran @praveendran]

Our new article on alternative splicing of the chromatin remodeling factor BAZ1A in CRC is now published. Check the link below-

https://t.co/3aPaNnTOv4

[Praveen Rajendran @praveendran]

Thrilled to share our latest review articles pushing the boundaries of epigenetics research! 🧬✨ Check them out: "Histone Acyl Code" https://t.co/JPHYupEABi “A-Z of Epigenetic Readers” https://t.co/AVUpvZl70P A big thank you to our team @TAMUHealth_CEDP @TAMU_IBT !

[Praveen Rajendran @praveendran]

Colorectal cancer and COVID-19: Inhibitors to combat both https://t.co/cbPhnzyLwg

['Field-to-Clinic' Epigenetics @TAMUHealth_CEDP]

Congratulations to Dr. Praveen Rajendran for selection as the 2023 Alkek Early Career Investigator Fellowship Award recipient! This award recognizes @praveendran for research that is highly innovative, transformational, and of great translational potential.

[Intestinal Cell News @Intestinal_Cell]

Drs. @praveendran, Roderick Dashwood, and their team at @TAMUHealth show that knockdown, forced overexpression, and inhibition of ACE2 in human #ColonCancer cells target 🎯 ACE2-BRD4 crosstalk to mediate marked changes in DNA 🧬 damage and apoptosis.

✔️ https://t.co/ZA6zYyjIu5

[Eduardo Vilar @evilarsan]

👏 What a great surprise! It is going to be so much fun to do this project with my long time collaborator and friend Rod Dashwood @TAMUHealth_CEDP 'Immunoepigenetic targeting of the MHC in FAP' Amazing team @praveendran Krishna Sinha @LesinskiLab Grateful for the opportunity 🙏

[Praveen Rajendran @praveendran]

Assaults at Schools - PROTECT THE VICTIM https://t.co/FwMj0N9sJk via @Change

['Field-to-Clinic' Epigenetics @TAMUHealth_CEDP]

New study shows a diet rich in spinach can significantly reduce the formation of colon tumors! 🥬💪

https://t.co/XHQt87CB5q

[Eduardo Vilar @evilarsan]

So proud to be leading this clinical trial! For our patients with #LynchSyndrome & their families Along with great collaborators Greg Idos @cityofhope @doctormikehall @FoxChaseCancer @mcruzcorrea @UPR_Oficial

[Oded Rechavi @OdedRechavi]

PI after using track changes on a student’s draft

[Dr. Ron DePinho @RonDePinho]

Making excellence progress on #COVID19 in #Houston -- infections down, positivity rate down, hospitalizations down. Don't be the last death ... please #GetVaccinated

[Eduardo Vilar @evilarsan]

📢 Honored to be recognized among Champions and Changemakers by @NCIprevention to commemorate 50th 🎂 #NationalCancerAct #PreventionIsKey #CancerPrevention @NCICastle @NCIDirector @MDAndersonNews 🙏Thankful to my patients, mentors, collaborators, family https://t.co/jYwEi2sPzd

[Cancer Research Institute @CancerResearch]

When you’re a T cell looking for a non-immunogenic tumor.

[Praveen Rajendran @praveendran]

Moin took his place, may be :)